Joon Lee
Stock Analyst at Truist Securities
(3.03)
# 474
Out of 5,370 analysts
135
Total ratings
55.70%
Success rate
40.75%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
VKTX Viking Therapeutics | Reiterates: Buy | 95 75 | 26.95 | 178.29% | 8 | Apr 28, 2025 | |
ARVN Arvinas | Maintains: Buy | 65 21 | 7.38 | 184.55% | 6 | Apr 9, 2025 | |
CORT Corcept Therapeutics | Maintains: Strong Buy | 76 150 | 70.84 | 111.74% | 8 | Mar 31, 2025 | |
NTLA Intellia Therapeutic... | Maintains: Buy | 90 50 | 8.96 | 458.04% | 4 | Mar 4, 2025 | |
PRAX Praxis Precision Med... | Maintains: Buy | 175 85 | 43.77 | 94.2% | 5 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 190 200 | 101.88 | 96.31% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 100 120 | 41.66 | 188.05% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 460 520 | 450.66 | 15.39% | 3 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 2.87 | 527.18% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 660 700 | 551.73 | 26.87% | 12 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 16 | 5.05 | 216.83% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 44 57 | 92.58 | -38.43% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 17 36 | 6.84 | 426.32% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 30 36 | 23.66 | 52.16% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 8 | 2.15 | 272.09% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 13 8 | 9.06 | -11.7% | 11 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 17 | 14.37 | 18.3% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 60 60 | n/a | n/a | 2 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 118 90 | 56.19 | 60.17% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 40 | 2.46 | 1526.02% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 10 | n/a | n/a | 7 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 200 | 109.64 | 82.42% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 5 | 2.54 | 96.85% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 3.31 | 443.81% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 25 | n/a | n/a | 2 | Sep 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 280 | 3.1 | 8932.26% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 45 50 | n/a | n/a | 1 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 360 | n/a | n/a | 2 | Mar 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 27 34 | 23.89 | 42.32% | 1 | Mar 16, 2021 |